Navigation Links
Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
Date:4/23/2008

- Final Safety and Efficacy Data Presented at 1st IASLC-ESMO European Lung

Cancer Conference -

SOUTH SAN FRANCISCO, Calif., April 23 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that final efficacy results from its Phase 2 clinical trial of picoplatin confirming previously announced interim results showing a survival benefit in patients with recurrent small cell lung cancer (SCLC) who have failed prior platinum-containing first-line chemotherapy or who have progressed within six months of first-line therapy. The median overall survival rate was 27 weeks and both this efficacy and the safety profile compares favorably with current medical treatments which often include palliative best supportive care. Best supportive care has been shown previously to have a median overall survival of 14 weeks and is the comparator arm for the ongoing randomized Phase 3 trial to evaluate picoplatin treatment in this patient setting. The final data were presented during a poster discussion session at the 1st European Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO).

"These final Phase 2 data show that picoplatin extended survival in patients with small cell lung cancer refractory to, or relapsing within 6 months of first-line platinum based chemotherapy," said Robert De Jager, M.D., chief medical officer of Poniard. "Based on promising results from this trial, we initiated our ongoing Phase 3 SPEAR trial in small cell lung cancer. We are targeting commercialization of picoplatin for use in SCLC in 2010. We are committed to developing picoplatin as a new generation chemotherapy agent addressing multiple i
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) ... Market (Indwelling or Foley Catheters, Intermittent Catheters and Male ... Share, Growth, Trends and Forecast 2014 - 2020" ... present, the global market for urinary catheters is experiencing ...
(Date:1/23/2015)... Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... therapies for operable and inoperable solid tumor cancers, announced today ... 7 th Annual Phacilitate Immunotherapy Forum in ... Phacilitate will take place on January 26 at 10:30 a.m. ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... PITTSBURGH , Feb. 3 An era ... together to fight cancer.  Now, drug response markers such as ... to determine individual cancer treatment plans when using various chemotherapeutic ... Inc., a life sciences company in Pittsburgh, Pennsylvania . ...
... PITTSBURGH , Feb. 3 Foundation Radiology Group ... downtown Pittsburgh , is pleased to announce its new division, ... and PET/CT imaging pioneer, Todd M. Blodgett , M.D.. ... as the Chief of Cancer Imaging at the University of ...
Cached Medicine Technology:Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 2Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 3Foundation Radiology Group Announces FRG Molecular Imaging Division, Led By Todd M. Blodgett, M.D. 2Foundation Radiology Group Announces FRG Molecular Imaging Division, Led By Todd M. Blodgett, M.D. 3
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the main ... , Auto insurance quotes help many drivers find the ... to call an agent or visit an agency for price ... website: http://autocarinsurancebest.com/ . , Every business who relies heavily ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... LOS ANGELES, Sept. 10 Award-winning actresses Edie Falco and Cynthia ... service campaign to educate cancer patients and their loved ones about ... of learning how to manage one,s risk. , , ... http://www.prnewswire.com/mnr/amgen/39907/ , , (Photo: ...
... , , , ... for cranial remolding on the road with the company,s new Mobile STAR Cranial ... shape scanning system that scans a child,s head in less than two seconds. ... wherever the unit travels, and the van is also equipped with the necessary ...
... , , , Council ... Experts at First in a Series of Briefings About Achieving "Recovery ... 10 Immigration and education policy experts gathered on Capitol Hill ... innovation. The briefing, titled Education & Immigration: The Building ...
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased ... order for the MammoView(TM) line of surgical endoscopy instruments ... boasts one of the most comprehensive health-care networks in ... staffed by University Physicians, offering the finest primary, secondary ...
... But not treating problems resulted in roughly same outcome, ... -- Treatment can help workers with mental health problems ... have high levels of mental stress seemed to have ... investigators looked at statistics regarding mental health and productivity ...
... , , FOSTER CITY, ... today that it has closed a $6 million series A round ... by X/Seed Capital, which also co-invested in the Series A. Concurrent ... seats on the company,s board. , , ...
Cached Medicine News:Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 2Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 3Health News:New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities 2Health News:New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities 3Health News:New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities 4Health News:New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities 5Health News:U.S. Leadership in Medical Innovation Depends on Education and Immigration Policy, Say Experts at Capitol Hill Briefing on 'Education & Immigration: Building Blocks of Innovation' 2Health News:U.S. Leadership in Medical Innovation Depends on Education and Immigration Policy, Say Experts at Capitol Hill Briefing on 'Education & Immigration: Building Blocks of Innovation' 3Health News:U.S. Leadership in Medical Innovation Depends on Education and Immigration Policy, Say Experts at Capitol Hill Briefing on 'Education & Immigration: Building Blocks of Innovation' 4Health News:Solos Endoscopy, Inc. Receives Purchase Order from One of the Major Healthcare Systems in Missouri 2Health News:Treating Workers' Mental Woes May Boost Productivity 2Health News:VitaPath Genetics Raises $6M in Series A Round 2
... IEC60601-2-51 new international standard for digital ... performance. ECG data can be reviewed ... with the optional ECG Viewer software. ... in other countries, and it truly ...
... The Stat Profile pHOx series consists of six ... and critical care profiles. Measured tests include pH, ... %, hematocrit, hemoglobin, sodium, potassium, ionized calcium, chloride, ... less than one minute. Its space saving design ...
... 25 years, Bio-logic has demonstrated continuous innovations ... introduced the first Digital EEG system brings ... you! Ceegraph VISION is the first Windows ... to integrate all your EEG needs: epilepsy ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: